Kuros Biosurgery Granted Patent for Bone Generation Drug/Biologic

Kuros Biosurgery was granted European Patent No 2686027, Pharmaceutical Formulation for Use in Spinal Fusion. This patent claims certain matrix materials in combination with parathyroid hormone (PTH) or derivatives of PTH.

The patent strengthens the intellectual property around Fibrin-PTH, Kuros’s drug/biologic combination product for bone...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0